WENDUINE PHARMA
0425.384.986 · rovalta.com · 25/09/2026
ACTIVE
WENDUINE PHARMA
Financial year 2025 · Closed on 31/12/2025
Net result74,2 k €+51,6 %over 1 year
Gross margin369 k €+12,3 %over 1 year
Equity1,1 M €+7,4 %over 1 year
Workforce3,0 ETP-9,1 %over 1 year
Overview
Identity
Source · BCE/KBOWENDUINE PHARMA is a Private limited company incorporated in 1983. Its registered office is in De Haan. It employs on average 3,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0425.384.986
- Incorporation
- 28/12/1983
- Legal form
- Private limited company
- Registered office
- Kerkstraat 7
8420 De Haan · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,0 ETP
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 20 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 369 k € | +12.3% | 328,7 k € | +94.3% | 169,1 k € | +20.2% | 140,8 k € | -35.4% | 218 k € |
| EBITDA | 170,8 k € | +23.6% | 138,2 k € | +1277% | 10 k € | -78.9% | 47,6 k € | -35.3% | 73,6 k € |
| Operating result | 99,8 k € | +49.0% | 67 k € | +224% | -54,1 k € | -340% | 22,5 k € | -54.1% | 49 k € |
| Net result | 74,2 k € | +51.6% | 48,9 k € | +190% | -54,4 k € | -313% | 25,5 k € | -39.4% | 42,2 k € |
| Balance sheet | |||||||||
| Equity | 1,1 M € | +7.4% | 1 M € | +5.1% | 959 k € | -34.2% | 1,5 M € | +1.8% | 1,4 M € |
| Total assets | 1,2 M € | +6.2% | 1,2 M € | -2.3% | 1,2 M € | -28.8% | 1,7 M € | +5.5% | 1,6 M € |
| Cash | 4,7 k € | -11.0% | 5,3 k € | -31.0% | 7,7 k € | +28.9% | 6 k € | -33.4% | 9 k € |
| Debts | 165,3 k € | -0.6% | 166,3 k € | -31.7% | 243,4 k € | +4.8% | 232,2 k € | +37.0% | 169,5 k € |
| Other | |||||||||
| Workforce | 3,0 ETP | -9.1% | 3,3 ETP | +6.5% | 3,1 ETP | +47.6% | 2,1 ETP | -4.5% | 2,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/2025Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 12/05/2026 | 16/06/2025 | 11/06/2024 | 09/06/2023 | 07/06/2022 | 14/06/2021 |
| General meeting | 03/04/2026 | 04/04/2025 | 05/04/2024 | 07/04/2023 | 01/04/2022 | 02/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 03/04/2026 | 12/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 04/04/2025 | 16/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 05/04/2024 | 11/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 07/04/2023 | 09/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/04/2022 | 07/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 02/04/2021 | 14/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 03/04/2020 | 13/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 05/04/2019 | 09/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 06/04/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 07/04/2017 | 10/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/04/2016 | 13/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 03/04/2015 | 27/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 04/04/2014 | 21/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 05/04/2013 | 27/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 06/04/2012 | 13/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 06/05/2011 | 29/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 20/06/2010 | 19/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 21/06/2009 | 25/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 15/06/2008 | 23/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 01/03/2007 | 29/03/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates23/07/2026ONTSLAGEN - BENOEMINGEN
- Mandates29/08/2023ONTSLAGEN - BENOEMINGEN
- Mandates02/12/2022ONTSLAGEN - BENOEMINGEN
- Mandates07/01/2021WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
- Mandates27/04/2012ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Mandates04/03/2011ONTSLAGEN - BENOEMINGEN
- Capital / shares18/02/2004STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202574,2 k €↑
- 2024Annual accounts 202448,9 k €↑
- 2024Name change028 - Wenduine Pharma
- 2023Annual accounts 2023-54,4 k €↓
- 2022Annual accounts 202225,5 k €↓
- 2021Annual accounts 202142,2 k €↑
- 2021Name changeWenduine Pharma
- 2020Annual accounts 2020-8,9 k €↓
- 2019Annual accounts 201912,7 k €↓
- 2018Annual accounts 2018111,1 k €↑
- 2017Annual accounts 201764,4 k €↓
- 2016Annual accounts 2016118,7 k €↑
- 2015Annual accounts 201573,1 k €↓
- 2014Annual accounts 201495,6 k €↓
- 2013Annual accounts 2013120,2 k €↑
- 2012Annual accounts 2012116,7 k €↓
- 2011Annual accounts 2011126 k €↑
- 2010Annual accounts 2010107,4 k €↑
- 2009Annual accounts 200923,2 k €↑
- 2008Annual accounts 200822,3 k €
- 28/12/1983IncorporationPrivate limited company